142 related articles for article (PubMed ID: 9470810)
1. Clinicians' attitudes to clinical trials of cancer therapy.
Fallowfield L; Ratcliffe D; Souhami R
Eur J Cancer; 1997 Nov; 33(13):2221-9. PubMed ID: 9470810
[TBL] [Abstract][Full Text] [Related]
2. Barriers to participation in clinical trials: a physician survey.
Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
[TBL] [Abstract][Full Text] [Related]
3. Clinicians' attitudes towards clinical trials of cancer therapy.
Ford E; Jenkins V; Fallowfield L; Stuart N; Farewell D; Farewell V
Br J Cancer; 2011 May; 104(10):1535-43. PubMed ID: 21487408
[TBL] [Abstract][Full Text] [Related]
4. A population-based assessment of specialty physician involvement in cancer clinical trials.
Klabunde CN; Keating NL; Potosky AL; Ambs A; He Y; Hornbrook MC; Ganz PA
J Natl Cancer Inst; 2011 Mar; 103(5):384-97. PubMed ID: 21317382
[TBL] [Abstract][Full Text] [Related]
5. Organizational barriers to physician participation in cancer clinical trials.
Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.
Kaplan CP; Nápoles AM; Dohan D; Shelley Hwang E; Melisko M; Nickleach D; Quinn JA; Haas J
Cancer Causes Control; 2013 May; 24(5):979-88. PubMed ID: 23420328
[TBL] [Abstract][Full Text] [Related]
7. Barriers to clinical trial participation as perceived by oncologists and patients.
Meropol NJ; Buzaglo JS; Millard J; Damjanov N; Miller SM; Ridgway C; Ross EA; Sprandio JD; Watts P
J Natl Compr Canc Netw; 2007 Sep; 5(8):655-64. PubMed ID: 17927923
[TBL] [Abstract][Full Text] [Related]
8. Views of American oncologists about the purposes of clinical trials.
Joffe S; Weeks JC
J Natl Cancer Inst; 2002 Dec; 94(24):1847-53. PubMed ID: 12488478
[TBL] [Abstract][Full Text] [Related]
9. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists.
Ellis PM; Butow PN; Simes RJ; Tattersall MH; Dunn SM
Aust N Z J Surg; 1999 Jul; 69(7):486-91. PubMed ID: 10442918
[TBL] [Abstract][Full Text] [Related]
10. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study.
Benson AB; Pregler JP; Bean JA; Rademaker AW; Eshler B; Anderson K
J Clin Oncol; 1991 Nov; 9(11):2067-75. PubMed ID: 1941065
[TBL] [Abstract][Full Text] [Related]
11. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists.
Siminoff LA; Zhang A; Colabianchi N; Sturm CM; Shen Q
J Clin Oncol; 2000 Mar; 18(6):1203-11. PubMed ID: 10715289
[TBL] [Abstract][Full Text] [Related]
12. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
Townsley CA; Chan KK; Pond GR; Marquez C; Siu LL; Straus SE
BMC Cancer; 2006 Feb; 6():34. PubMed ID: 16466574
[TBL] [Abstract][Full Text] [Related]
13. Clinicians' attitudes to recruitment to randomised trials in cancer care: a qualitative study.
Langley C; Gray S; Selley S; Bowie C; Price C
J Health Serv Res Policy; 2000 Jul; 5(3):164-9. PubMed ID: 11183627
[TBL] [Abstract][Full Text] [Related]
14. Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved Populations.
Perez GK; Oberoi AR; Finkelstein-Fox L; Park ER; Nipp RD; Moy B
Cancer Control; 2023; 30():10732748231187829. PubMed ID: 37724824
[TBL] [Abstract][Full Text] [Related]
15. Surgical and oncology trials for rectal cancer: who will participate?
Harrison JD; Solomon MJ; Young JM; Meagher A; Hruby G; Salkeld G; Clarke S
Surgery; 2007 Jul; 142(1):94-101. PubMed ID: 17630005
[TBL] [Abstract][Full Text] [Related]
16. Seeking informed consent to Phase I cancer clinical trials: identifying oncologists' communication strategies.
Brown R; Bylund CL; Siminoff LA; Slovin SF
Psychooncology; 2011 Apr; 20(4):361-8. PubMed ID: 20878842
[TBL] [Abstract][Full Text] [Related]
17. Oncologists' knowledge, attitudes and practices related to cancer treatment clinical trials.
Kaanoi M; Braun KL; Gotay CC; Abrigo L
Hawaii Med J; 2002 May; 61(5):91-5. PubMed ID: 12073745
[TBL] [Abstract][Full Text] [Related]
18. Barriers to participation in cancer prevention clinical trials.
Hall MJ; Egleston B; Miller SM; Buzaglo JS; Millard J; Ridgway C; Damjanov N; Sprandio JD; Meropol NJ
Acta Oncol; 2010 Aug; 49(6):757-66. PubMed ID: 20515420
[TBL] [Abstract][Full Text] [Related]
19. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
20. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators.
Taylor KM; Feldstein ML; Skeel RT; Pandya KJ; Ng P; Carbone PP
J Clin Oncol; 1994 Sep; 12(9):1796-805. PubMed ID: 8083703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
